Mesco Pharmaceuticals Ltd Financials
Company Logo

Mesco Pharmaceuticals Ltd Financial Statement

Mesco Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Dec 2021
RevenueTBA
Operating ExpenseTBA
Net ProfitTBA
Net Profit MarginTBA
Earning Per ShareTBA
EBIDTATBA
Effective Tax RateTBA
Invest in Mesco Pharmaceuticals Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Mesco Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2021
Total Revenue AnnualTBA
Operating Expenses Annual0.00
Operating Profit Annual-0.00
Interest Annual0.00
DepreciationTBA
Net Profit Annual-0.00
Tax AnnualTBA

Mesco Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2021
Cash Flow at the Beginning0.04
Cash Flow from OperationsTBA
Cash Flow from InvestingTBA
Cash Flow from Financing-0.03
Cash Flow at the EndTBA

Mesco Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2021
PBDIT Margin (%)TBA
PBIT Margin (%)TBA
PBT Margin (%)TBA
Net PROFIT Margin (%)TBA
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)TBA
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)TBA

Mesco Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2021
Fixed Assets Annual0.18
Total Current Assets Annual0.00
Non Current Assets Annual0.18
Total Shareholders Funds Annual-11.02
Total Assets Annual0.18

Mesco Pharmaceuticals Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 23, 2024, Mesco Pharmaceuticals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
Yes, Mesco Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of -1.02.
In FY 2023 , Mesco Pharmaceuticals Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.
Mesco Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and NaN% annually, respectively..
Mesco Pharmaceuticals Ltd's current PE ratio is 0.00.
Mesco Pharmaceuticals Ltd's ROCE averaged -77.7% from the FY ending March 2019 to 2021, with a median of -48.0%. It peaked at -2.4% in March 2021, reflecting strong capital efficiency over the period..
Mesco Pharmaceuticals Ltd's latest EBIT is Rs. 0 Cr, surpassing the average EBIT of Rs. -0.17 Cr over the 5 years..